(Q35021936)

5 August 2017

1 reference

title

Integrating quality into the cycle of therapeutic development (English)

1 reference

American Heart Association

5 August 2017

author

9

object named as

American Heart Association

1 reference

American College of Cardiology

5 August 2017

8

object named as

American College of Cardiology

1 reference

5 August 2017

1

Robert M Califf

1 reference

5 August 2017

2

Eric D Peterson

1 reference

5 August 2017

7

Sidney C Smith

1 reference

5 August 2017

Raymond J Gibbons

3

1 reference

5 August 2017

Arthur Garson

4

1 reference

5 August 2017

Ralph G Brindis

5

1 reference

5 August 2017

George A Beller

6

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Journal of the American College of Cardiology

5 August 2017

published in

1 reference

5 August 2017

volume

40

1 reference

5 August 2017

issue

11

1 reference

5 August 2017

page(s)

1895-1901

1 reference

A strategy for quality assurance in Medicare

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

How good is the quality of health care in the United States?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

President's page: integrating the internet into your practice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Long-term use of a left ventricular assist device for end-stage heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Surrogate end points in clinical trials: are we being misled?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Why do we need some large, simple randomized trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Principles from clinical trials relevant to clinical practice: Part I.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Users' Guides to the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exerting (more than) a class effect

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Natural statins and stroke risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Lessons learned from recent cardiovascular clinical trials: Part I.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Lessons learned from recent cardiovascular clinical trials: Part II.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Clinical judgment and therapeutic decision making

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Relationships between authors of clinical practice guidelines and the pharmaceutical industry

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Co

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Medical economics and the assessment of value in cardiovascular medicine: Part I.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

Improving the quality of health care in the United Kingdom and the United States: a framework for change

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902537-8

7 January 2021

10.1016/S0735-1097(02)02537-8

Identifiers

DOI

1 reference

5 August 2017

1 reference